Medtronic (MDT) Tops Q2 EPS by 3c, Maintains FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Medtronic, Inc. (MDT) PT Lowered to $142 at Guggenheim
November 24, 2021 8:05 AM ESTGuggenheim analyst Chris Pasquale lowered the price target on Medtronic, Inc. (NYSE: MDT) to $142.00 (from $148.00) while maintaining a Buy rating.
The analyst commented, "MDT reported FY2Q22 revenue below Consensus estimates, though relatively in-line with weakened sentiment, in our view, while adj.... More
Medtronic, Inc. (MDT) PT Lowered to $140 at Stifel
November 23, 2021 5:49 PM ESTStifel analyst Rick Wise lowered the price target on Medtronic, Inc. (NYSE: MDT) to $140.00 (from $145.00) while maintaining a Buy rating following earnings.
The analyst commented, "We were hopeful that Medtronics F2Q22 (Oct.) would reflect more-visible US procedure volume recovery/improvements. This... More
Medtronic, Inc. (MDT) PT Lowered to $145 at Needham & Company
November 23, 2021 1:27 PM ESTNeedham & Company analyst Michael Matson lowered the price target on Medtronic, Inc. (NYSE: MDT) to $145.00 (from $152.00) while maintaining a Buy rating.
The analyst commented, "MDT's F2Q22 revenue missed consensus while EPS beat consensus and organic revenue growth slowed to 2.2% from 19.0% in... More
